Treatments
927 articles
Testing the Effectiveness of Immunotherapy Added to a New Drug Combination
Researchers are testing a drug combination that adds immunotherapy to standard drugs used to treat pancreatic cancer and an antimalarial drug.
The Positive Impact of a Pancreatic Cancer Clinical Trial
Richard Blish was a healthy, athletic 67-year-old when he developed symptoms of pancreatic cancer. His daughter steered him to a clinical trial for treatment.
Pancreatic Cancer Caught Early by Chance
Sandra Wilke chose her pancreatic cancer treatment of chemotherapy and pancreatectomy with an eye to her quality of life. She joined the tumor registry to learn more and help others.
Prognosis: More Than Numbers in Pancreatic Cancer
What is pancreatic cancer prognosis? Dr. Joshua Lakin of Harvard explains how prognosis works, and ways to possibly defy the odds when facing a slow recovery.
Fleeting, Fragile, and Funny
Eric Egelman had molecular profiling of his tumor and a KRAS mutation was found. This qualified him for a vaccine clinical trial.
Genetic Testing and Molecular Profiling Can Guide Treatment
Watch our webinar on Genetic Testing and Molecular Profiling to learn from experts and patients why this is so important.
Extensive Family History and Genetic Testing Leads to Early Detection
Sidney Levinson and his doctor were aware of his BRCA1/2 mutations so when an MRI was recommended for screening, Sidney did it.
AVENGER 500 Clinical Trial Shows No Overall Survival Benefit
Data from the AVENGER 500 clinical trial explains why the trial’s goal was not met. A new trial with a different approach has launched.
Making My Own Choices for Quality Time
After her pancreatectomy Margo Chilcott decided to forgo chemotherapy and radiation to spend more quality time with her grandchildren and great-grandchildren.
Can SBRT Become More Effective?
Radiation oncologist Dr. Todd Aguilera is looking for ways to make SBRT a more effective treatment for pancreatic cancer.
Enhancing Standard Chemotherapy in Metastatic Pancreatic Cancer
Researchers are testing a new kinase inhibitor as a way to make standard chemotherapy more effective against advanced pancreatic cancer.
A Two-Part Journey, So Far
Three years after surgery to remove a pancreatic neuroendocrine tumor from the tail of his pancreas, Pablo Rodriguez was shocked to discover the cancer had returned.
A Fighting Spirit
Resilience best describes Dr. Errol D. Toulon, Jr., a long-term survivor of lymphoma, pancreatic cancer, and a heart emergency.
Who Should Be Screened For Pancreatic Cancer
Who should be screened for pancreatic cancer? Dr. Allyson Ocean explains how genetic mutations and family history factor into screening.
Going After a Specialized Radiation Treatment
Don Myrah wanted more than chemotherapy. He read about a specialized radiation treatment and directly contacted the company behind it.